Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis, 2014 Update

Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis, 2014 Update

Summary

Ortho-Clinical Diagnostics, Inc. (OCD) is a provider of vitro diagnostic products. The company designs, develops, manufactures and distributes in-vitro diagnostic products for the healthcare markets. The company serves clinical laboratories by providing total solutions for screening, diagnosing, monitoring and confirming diseases early. It also serves global transfusion medicine community by offering donor screening and blood typing products. The company's services includes e-connectivity, customer service and support, customer technical support center, field engineer service, predictive technologies center, Ortho Plus SM services, product training and consulting services. The company, with manufacturing operations in Rochester New York, Pompano Beach, Florida and Pencoed, Wales, offers its products and services in North America, Latin America, Europe and Asia Pacific. The company is a subsidiary of Johnson & Johnson. Ortho-Clinical is headquartered in Raritan, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ortho-Clinical Diagnostics Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents

Ortho-Clinical Diagnostics Inc. Company Snapshot 5
Ortho-Clinical Diagnostics Inc. Company Overview 5
Key Information 5
Ortho-Clinical Diagnostics Inc. Pipeline Products and Clinical Trials Overview 6
Ortho-Clinical Diagnostics Inc. - Pipeline Analysis Overview 8
Business Description 8
Key Facts 9
Ortho-Clinical Diagnostics Inc. - Major Products and Services 10
Ortho-Clinical Diagnostics Inc. Pipeline Products by Development Stage 12
Ortho-Clinical Diagnostics Inc. Pipeline Products Overview 14
Next Generation VITROS System 14
Next Generation VITROS System Product Overview 14
ORTHO AutoVue - Rare Sera Assay 15
ORTHO AutoVue - Rare Sera Assay Product Overview 15
ORTHO BioVue - Rare Sera Assay 16
ORTHO BioVue - Rare Sera Assay Product Overview 16
ORTHO VISION Blood Analyzer 17
ORTHO VISION Blood Analyzer Product Overview 17
OrthoVision Max 18
OrthoVision Max Product Overview 18
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay 19
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay Product Overview 19
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay 20
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay Product Overview 20
VITROS Eci - HIV Combo Assay 21
VITROS Eci - HIV Combo Assay Product Overview 21
VITROS EciQ - HIV-1/2/O Ag/Ab Combo Assay 22
VITROS EciQ - HIV-1/2/O Ag/Ab Combo Assay Product Overview 22
Ortho-Clinical Diagnostics Inc. - Key Competitors 23
Ortho-Clinical Diagnostics Inc. - Key Employees 24
Ortho-Clinical Diagnostics Inc. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 28
Ortho-Clinical Diagnostics Inc., Recent Developments 28
Aug 13, 2013: Avioq Announces Health Canada Approval and Canadian Launch of HTLV-I/II Test 28
Apr 10, 2013: Avioq Announces CE Mark And European Launch Of HTLV-I/II Test 28
Dec 19, 2012: Hospitals, Healthcare Providers To Benefit From New Multi-Source Premier Agreements For Blood Bank Analyzers, Reagents, Consumables And Service 28
Jul 25, 2012: Ortho Clinical Diagnostics launches new virtual engagement platform for the blood banking community 29
Jun 11, 2012: Ortho-Clinical Receives CE Mark For Total PSA II Assay 29
Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 29
Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 30
Mar 28, 2012: Ortho-Clinical Announces Availability Of Avioq HTLV-I/II Microelisa System Assay 30
Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 31
Jul 22, 2011: Ortho Clinical Diagnostics Launches VITROS 4600 Chemistry System For Mid-To High-Volume Laboratories 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables

Ortho-Clinical Diagnostics Inc., Key Facts 5
Ortho-Clinical Diagnostics Inc. Pipeline Products and Clinical Trials Overview 6
Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 6
Ortho-Clinical Diagnostics Inc. Pipeline Products by Indication 7
Ortho-Clinical Diagnostics Inc., Key Facts 9
Ortho-Clinical Diagnostics Inc., Major Products and Services 10
Ortho-Clinical Diagnostics Inc. Number of Pipeline Products by Development Stage 12
Ortho-Clinical Diagnostics Inc. Pipeline Products Summary by Development Stage 13
Next Generation VITROS System - Product Status 14
Next Generation VITROS System - Product Description 14
ORTHO AutoVue - Rare Sera Assay - Product Status 15
ORTHO AutoVue - Rare Sera Assay - Product Description 15
ORTHO BioVue - Rare Sera Assay - Product Status 16
ORTHO BioVue - Rare Sera Assay - Product Description 16
ORTHO VISION Blood Analyzer - Product Status 17
ORTHO VISION Blood Analyzer - Product Description 17
OrthoVision Max - Product Status 18
OrthoVision Max - Product Description 18
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay - Product Status 19
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay - Product Description 19
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay - Product Status 20
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay - Product Description 20
VITROS Eci - HIV Combo Assay - Product Status 21
VITROS Eci - HIV Combo Assay - Product Description 21
VITROS EciQ - HIV-1/2/O Ag/Ab Combo Assay - Product Status 22
VITROS EciQ - HIV-1/2/O Ag/Ab Combo Assay - Product Description 22
Ortho-Clinical Diagnostics Inc., Key Employees 24
Ortho-Clinical Diagnostics Inc., Other Locations 25
Ortho-Clinical Diagnostics Inc., Subsidiaries 26

List of Figures

Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 6
Ortho-Clinical Diagnostics Inc. Pipeline Products by Development Stage 12